This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Mar 4;362(9):858-9.

doi: 10.1056/NEJMc0911925.

Capecitabine and oxaliplatin for advanced esophagogastric cancer

David Cunningham, Alicia F C Okines, Sue Ashley

PMID: 20200397
DOI: 10.1056/NEJMc0911925

Comment

Capecitabine and oxaliplatin for advanced esophagogastric cancer

David Cunningham et al. N Engl J Med. 2010.

. 2010 Mar 4;362(9):858-9.

doi: 10.1056/NEJMc0911925.

Authors

David Cunningham, Alicia F C Okines, Sue Ashley

PMID: 20200397
DOI: 10.1056/NEJMc0911925

No abstract available

PubMed Disclaimer

Comment on

Capecitabine and oxaliplatin for advanced esophagogastric cancer.
Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR; Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom. Cunningham D, et al. N Engl J Med. 2008 Jan 3;358(1):36-46. doi: 10.1056/NEJMoa073149. N Engl J Med. 2008. PMID: 18172173 Clinical Trial.

Similar articles

Capecitabine and oxaliplatin for advanced esophagogastric cancer.
Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR; Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom. Cunningham D, et al. N Engl J Med. 2008 Jan 3;358(1):36-46. doi: 10.1056/NEJMoa073149. N Engl J Med. 2008. PMID: 18172173 Clinical Trial.
Can cisplatin and infused 5-fluorouracil be replaced by oxaliplatin and capecitabine in the treatment of advanced oesophagogastric cancer? The REAL 2 trial.
Chong G, Cunningham D. Chong G, et al. Clin Oncol (R Coll Radiol). 2005 Apr;17(2):79-80. doi: 10.1016/j.clon.2004.12.004. Clin Oncol (R Coll Radiol). 2005. PMID: 15830568 No abstract available.
Capecitabine and oxaliplatin for advanced esophagogastric cancer.
Bölke E, Peiper M, Budach W. Bölke E, et al. N Engl J Med. 2008 May 1;358(18):1965; author reply 1965. doi: 10.1056/NEJMc080178. N Engl J Med. 2008. PMID: 18450611 No abstract available.
[Progress in chemotherapy for advanced gastric cancer].
Xu RH, Teng KY. Xu RH, et al. Ai Zheng. 2009 Oct;28(10):1108-13. doi: 10.5732/cjc.008.10560. Ai Zheng. 2009. PMID: 19799823 Review. Chinese.
Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.
Norman G, Rice S, Spackman E, Stirk L, Danso-Appiah A, Suh D, Palmer S, Eastwood A. Norman G, et al. Health Technol Assess. 2011 May;15 Suppl 1:33-42. doi: 10.3310/hta15suppl1/04. Health Technol Assess. 2011. PMID: 21609651 Review.

See all similar articles

Cited by

Trimodality therapy for stage II-III carcinoma of the esophagus: a dose-ranging study of concurrent capecitabine, docetaxel, and thoracic radiotherapy.
Wood MD, Zaki BI, Gordon SR, Sutton JE Jr, Lisovsky M, Gui J, Bubis JA, Dragnev KH, Rigas JR. Wood MD, et al. J Thorac Oncol. 2013 Apr;8(4):487-94. doi: 10.1097/JTO.0b013e3182829bf3. J Thorac Oncol. 2013. PMID: 23370365 Free PMC article.
A phase II study of biweekly oxaliplatin plus S-1 combination chemotherapy as a first-line treatment for patients with metastatic or advanced gastric cancer in China.
Xiao C, Qian J, Zheng Y, Song F, Wang Q, Jiang H, Mao C, Xu N. Xiao C, et al. Medicine (Baltimore). 2019 May;98(20):e15696. doi: 10.1097/MD.0000000000015696. Medicine (Baltimore). 2019. PMID: 31096513 Free PMC article. Clinical Trial.
Effectiveness and Safety of Apatinib Plus Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer: A Nonrandomized Controlled Trial.
Lin JX, Xu YC, Lin W, Xue FQ, Ye JX, Zang WD, Cai LS, You J, Xu JH, Cai JC, Tang YH, Xie JW, Li P, Zheng CH, Huang CM. Lin JX, et al. JAMA Netw Open. 2021 Jul 1;4(7):e2116240. doi: 10.1001/jamanetworkopen.2021.16240. JAMA Netw Open. 2021. PMID: 34241629 Free PMC article.
A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO).
Hall PS, Lord SR, Collinson M, Marshall H, Jones M, Lowe C, Howard H, Swinson D, Velikova G, Anthoney A, Roy R, Dent J, Cheeseman S, Last K, Seymour MT. Hall PS, et al. Br J Cancer. 2017 Feb 14;116(4):472-478. doi: 10.1038/bjc.2016.442. Epub 2017 Jan 17. Br J Cancer. 2017. PMID: 28095397 Free PMC article. Clinical Trial.
[Bladder metastasis of signet ring gastric adenocarcinoma].
Seddik Y, Al Jarroudi O, Brahmi SA, Afqir S. Seddik Y, et al. Pan Afr Med J. 2014 Oct 27;19:206. doi: 10.11604/pamj.2014.19.206.4966. eCollection 2014. Pan Afr Med J. 2014. PMID: 25821549 Free PMC article. French.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information